Mark Miller, Vice President, Corporate Business Development, Lilly, presented at last year's World Orphan Drug Congress USA on the topic âLeveraging licensing and acquisitions to enter orphan disease research successfully.'
Do you want to learn more about:
- Interest in orphan diseases and vision of the future
- Challenges that need to be overcome
- Strategy for entering the orphan disease area and implementing strategy
If so, you need to check out the video below: